Warren M Kati Selected Research

Warren M Kati Research Topics

9	Neoplasms (Cancer) 01/2023 - 01/2017
6	Infections 01/2022 - 04/2002
4	Human Influenza (Influenza) 03/2008 - 04/2002
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2022 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 01/2020
2	Hepatitis C 03/2011 - 01/2004
1	Primary Myelofibrosis (Myelosclerosis) 07/2022
1	COVID-19 01/2022
1	Breakthrough Infections 01/2022
1	Virus Diseases (Viral Diseases) 01/2021
1	Inflammation (Inflammations) 10/2017
1	Carcinogenesis 01/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017
1	Multiple Myeloma 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017
1	Hyperbilirubinemia 04/2009

6	mivebresibIBA 07/2022 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
4	EnzymesIBA 01/2022 - 04/2002
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
3	Neuraminidase (Sialidase)IBA 03/2008 - 01/2005
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2004
2	ABBV-744IBA 10/2021 - 01/2020
2	pyrrolidineIBA 03/2008 - 06/2005
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2023
1	PapainIBA 01/2022
1	nirmatrelvir and ritonavir drug combinationIBA 01/2022
1	remdesivirIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	VaccinesIBA 01/2022
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AndrogensIBA 01/2020
1	Viekira PakIBA 10/2018
1	ombitasvirIBA 10/2018
1	NucleosidesIBA 01/2018
1	ABT-072IBA 01/2018
1	Bromodomain Containing ProteinsIBA 11/2017
1	venetoclaxIBA 01/2017
1	quinolineIBA 03/2011
1	BilirubinIBA 04/2009
1	AcidsIBA 01/2005
1	tetrahydrofuranIBA 01/2005
1	Carboxylic AcidsIBA 01/2005
1	Zanamivir (Relenza)FDA Link 04/2002
1	peramivirIBA 04/2002
1	A 315675IBA 04/2002
1	oseltamivir carboxylateIBA 04/2002
1	Oseltamivir (Tamiflu)FDA Link 04/2002

5	Therapeutics 01/2023 - 04/2002
1	Duration of Therapy 10/2018